UGT2B4 and prostate carcinoma: Further to examine the potential functional mechanism of UGT2B4 in prostate cancer, we performed the spearman correlation analysis of UGT2B4 in the expression data of the 497 prostate cancer patients from TCGA (Figure 5B).